Search
Search Constraints
You searched for: Author/Creator Van der Wielen, MarieLimit your search
- Van der Wielen, Marie [remove] 13
- 615.372 7
- Vaccines -- Periodicals 7
- 618.929 4
- Communicable diseases in children -- Periodicals 4
- Infection in children -- Periodicals 4
- 616.905 2
- Communicable diseases -- Periodicals 2
- ACIP Advisory Committee on Immunization Practices -- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- GMC geometric mean concentration -- GMT geometric mean titer -- Hib Haemophilus influenzae type b -- HIV human immunodeficiency virus -- hSBA serum bactericidal activity assay using human complement -- MenACWY-TT quadrivalent serogroups A, C, W and Y conjugate vaccine using tetanus toxoid as carrier protein -- IU international units -- PS polysaccharides -- rSBA serum bactericidal activity assay using rabbit complement -- SAE serious adverse event -- TVC total vaccinated cohort -- US United States -- VRR vaccine response rate 1
- AE adverse event -- ATP according-to-protocol -- CI confidence interval -- D diphtheria -- ELISA enzyme-linked immunosorbent assay -- FHA filamentous hemagglutinin -- GMC geometric mean concentration -- GMT geometric mean titer -- HibMenCY-TT Haemophilus influenzae -MenC/Y conjugate vaccine -- IMD invasive meningococcal disease -- IU international units -- Lf limit of flocculation -- LL lower limit -- MenA serogroup A -- MenC serogroups C -- MenW serogroup W -- MenY serogroups Y -- MenACWY-TT quadrivalent serogroups A, C, W and Y conjugate vaccine using tetanus toxoid as carrier protein -- MMRV measles-mumps-rubella-varicella vaccine -- NOCI new onset of chronic illness -- PRN pertactin -- PT pertussis toxin -- rSBA serum bactericidal assay using rabbit complement -- SAE serious adverse event -- T tetanus -- Tdap combined diphtheria-tetanus-acellular pertussis vaccine -- Tdap-HBV-IPV/Hib combined diphtheria-tetanus-acellular pertussis -hepatitis B-inactivated polio-Hib vaccine -- TVC total vaccinated cohort 1
- Asplenia -- Neisseria meningitidis -- Meningococcal disease -- Meningococcal vaccine -- Immunogenicity -- Safety 1